W.A. Thomas

2.4k total citations
88 papers, 1.9k citations indexed

About

W.A. Thomas is a scholar working on Surgery, Molecular Biology and Immunology. According to data from OpenAlex, W.A. Thomas has authored 88 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 22 papers in Molecular Biology and 19 papers in Immunology. Recurrent topics in W.A. Thomas's work include Cholesterol and Lipid Metabolism (19 papers), Atherosclerosis and Cardiovascular Diseases (18 papers) and Fatty Acid Research and Health (16 papers). W.A. Thomas is often cited by papers focused on Cholesterol and Lipid Metabolism (19 papers), Atherosclerosis and Cardiovascular Diseases (18 papers) and Fatty Acid Research and Health (16 papers). W.A. Thomas collaborates with scholars based in United States, Sweden and United Kingdom. W.A. Thomas's co-authors include K.T. Lee, Johannes Reiner, D.N. Kim, R.A. Florentin, R.F. Scott, S.C. Nam, Josef Schmee, H. Imai, Rose M. Jones and A.S. Daoud and has published in prestigious journals such as The Lancet, Circulation and The Journal of Cell Biology.

In The Last Decade

W.A. Thomas

86 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W.A. Thomas United States 26 620 475 443 387 315 88 1.9k
K.T. Lee United States 20 390 0.6× 316 0.7× 251 0.6× 181 0.5× 240 0.8× 55 1.2k
Johannes Reiner United States 19 241 0.4× 296 0.6× 164 0.4× 163 0.4× 76 0.2× 59 885
Shigeru Hokari Japan 18 401 0.6× 809 1.7× 205 0.5× 121 0.3× 209 0.7× 51 1.6k
Carrie B. Welch United States 10 541 0.9× 834 1.8× 159 0.4× 94 0.2× 103 0.3× 13 1.8k
Naohiko Kobayashi Japan 27 256 0.4× 614 1.3× 311 0.7× 105 0.3× 429 1.4× 55 1.8k
Myriam Bennoun France 18 285 0.5× 835 1.8× 184 0.4× 1.5k 3.9× 60 0.2× 31 3.6k
Helen J. Palmer United States 12 207 0.3× 508 1.1× 502 1.1× 69 0.2× 107 0.3× 15 1.4k
M C de Beer United States 20 535 0.9× 843 1.8× 149 0.3× 128 0.3× 66 0.2× 24 1.3k
Lorna P. Andersson United States 9 664 1.1× 1.1k 2.4× 762 1.7× 70 0.2× 100 0.3× 10 2.1k
Eugene S. Handler United States 22 551 0.9× 477 1.0× 723 1.6× 44 0.1× 152 0.5× 55 2.0k

Countries citing papers authored by W.A. Thomas

Since Specialization
Citations

This map shows the geographic impact of W.A. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.A. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.A. Thomas more than expected).

Fields of papers citing papers by W.A. Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.A. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.A. Thomas. The network helps show where W.A. Thomas may publish in the future.

Co-authorship network of co-authors of W.A. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of W.A. Thomas. A scholar is included among the top collaborators of W.A. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.A. Thomas. W.A. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davies, Emma, et al.. (2025). Is there a need to repeat single assay reactive HIV screens? A review of practice in two UK sites. Journal of Clinical Virology. 182. 105906–105906.
2.
Schmee, Josef, et al.. (1993). Exponential Relationship between Plasma Cholesterol Levels and Atherosclerotic Lesion Size in Hyperlipidemic Swine. Experimental and Molecular Pathology. 59(3). 177–185. 1 indexed citations
3.
Kim, D.N., Josef Schmee, James E. Baker, et al.. (1993). Dietary Fish Oil Reduces Microthrombi over Atherosclerotic Lesions in Hyperlipidemic Swine Even in the Absence of Plasma Cholesterol Reduction. Experimental and Molecular Pathology. 59(2). 122–135. 13 indexed citations
4.
Kim, D.N., et al.. (1991). Comparison of effects of fish oil and corn oil supplements on hyperlipidemic diet induced atherogenesis in swine. Atherosclerosis. 89(2-3). 191–201. 17 indexed citations
5.
Kim, D.N., et al.. (1991). Reductions in serum thromboxane, prostacyclin, and leukotriene B4 levels in swine fed a fish oil supplement to an atherogenic diet. Experimental and Molecular Pathology. 55(1). 1–12. 3 indexed citations
6.
Thomas, W.A., et al.. (1990). Retardation of Atherogenesis and Other Effects of a Fish Oil Additive to a Hyperlipidemic Diet for Swine. Annals of the New York Academy of Sciences. 598(1). 308–323. 2 indexed citations
7.
Kim, D.N., Josef Schmee, & W.A. Thomas. (1990). Dietary fish oil added to a hyperlipidemic diet for swine results in reduction in the excessive number of monocytes attached to arterial endothelium. Atherosclerosis. 81(3). 209–216. 35 indexed citations
8.
9.
Kim, D.N., R.F. Scott, Josef Schmee, & W.A. Thomas. (1988). Endothelial cell denudation, labelling indices and monocyte attachment in advanced swine coronary artery lesions. Atherosclerosis. 73(2-3). 247–257. 5 indexed citations
10.
Kim, D.N., et al.. (1988). The “turning off” of excessive cell replicative activity in advanced atherosclerotic lesions of swine by a regression diet. Atherosclerosis. 71(2-3). 131–142. 11 indexed citations
11.
Rogers, David, et al.. (1981). Circadian variation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in swine liver and ileum.. Journal of Lipid Research. 22(5). 811–819. 10 indexed citations
12.
Thomas, W.A., R.F. Scott, R.A. Florentin, Johannes Reiner, & K.T. Lee. (1981). Population dynamics of arterial cells during atherogenesis. Experimental and Molecular Pathology. 35(2). 153–162. 14 indexed citations
13.
Kim, D.N., et al.. (1980). Effect of clofibrate, cholestyramine, cholesterol and feeding pattern on the diurnal variation of cholesterol 7 alpha-hydroxylation in swine. Experimental and Molecular Pathology. 32(1). 52–60. 4 indexed citations
14.
Thomas, W.A.. (1979). Equitable considerations in balancing the energy equation.. Environmental Health Perspectives. 32. 255–258. 1 indexed citations
15.
Kim, D.N., K.T. Lee, Johannes Reiner, & W.A. Thomas. (1975). An evaluation of some of the potential immediate sources of cholesterol for bile acid synthesis in swine. Experimental and Molecular Pathology. 22(2). 284–293. 2 indexed citations
16.
Kim, D.N., K.T. Lee, Johannes Reiner, & W.A. Thomas. (1974). Restraint of cholesterol accumulation in tissue pools associated with drastic short-term lowering of serum cholesterol levels by clofibrate or cholestyramine in hypercholesterolemic swine. Journal of Lipid Research. 15(4). 326–331. 37 indexed citations
17.
Gordon, Donald L., et al.. (1972). Pathologic testicular findings in Klinefelter's syndrome. 47,XXY vs 46,XY-47,XXY.. PubMed. 130(5). 726–9. 49 indexed citations
18.
Florentin, R.A., et al.. (1969). STIMULATION OF DNA SYNTHESIS AND CELL DIVISION IN VITRO BY SERUM FROM CHOLESTEROL-FED SWINE. The Journal of Cell Biology. 41(2). 641–645. 23 indexed citations
19.
Shaper, A. G., et al.. (1962). Geographic studies pertaining to arteriosclerosis: comparison of fatty acid patterns of adipose tissue and plasma lipids in East Africans with those of North American white and Negro groups.. 74. 481–488. 21 indexed citations
20.
Thomas, W.A., et al.. (1957). Saturated versus unsaturated fats in experimental arteriosclerosis.. 63. 571–575. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026